Cite
HARVARD Citation
Wollenhaupt, J. et al. (n.d.). THU0197 Tofacitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in open-label, long-term extension studies over 8 years. Annals of the rheumatic diseases. pp. 277-278. [Online].